Thus, despite CXCR4 expression identifies DLBCL patients with poor prognosis; the patient subset expressing both CXCR7 and CXCR4 has an OS similar to that in CXCR4- patients. This evidence concerns the gene CXCR4 and diffuse large B-cell lymphoma.